NCT02107430View on ClinicalTrials.gov

Phase II Study of DCVAC/PCa After Primary Radiotherapy for Patients With High Risk Localized Prostate Cancer

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

September 30, 2013

Study Completion Date

October 31, 2018

Conditions

Prostate Cancer

Interventions

BIOLOGICAL

Dendritic Cells DCVAC/PCa

DCVAC/PCa arm post radiotherapy

RADIATION

Standard radiotherapy

radiotherapy

Trial Locations (6)

586 33

Nemocnice Jihlava,Urologické oddělení,, Jihlava

775 20

Fakultní nemocnice Olomouc, Olomouc

708 52

FN Ostrava, Onkologická klinika, Ostrava

100 34

FNKV Klinika radiologie a onkologie, Prague

150 06

FN Motol, Prague

180 00

Nemocnice Na Bulovce, Prague

All Listed Sponsors

lead

SOTIO a.s.

INDUSTRY

NCT02107430 - Phase II Study of DCVAC/PCa After Primary Radiotherapy for Patients With High Risk Localized Prostate Cancer | Biotech Hunter | Biotech Hunter